Patient-derived organoids in human cancer: A platform for fundamental research and precision medicine

Organoids, formed as intricate three-dimensional (3D) structures, hold the capacity to originate from a wide array of cellular sources, ranging from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to somatic stem cells and even cancer cells.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup